Based on our advanced algorithm, we predict that LEXX stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $0.8374, while the 1-week outlook suggests a value of $0.8491. For the 1-month forecast, we project a price of $0.8582. Looking further ahead, our 2026 projection estimates a value of $0.00, with a long-term 2030 forecast reaching $0.00. Stay informed and make strategic decisions with our data-driven insights!
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. LEXX has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
LEXX stock price ended at $0.8215 on Monday, after losing-2.72%
The Lexaria Bioscience Corp stock price decreased by -2.72% on the last trading day (11 Aug 2025), dropping from 0.84 to 0.8215. Throughout the last trading session, the stock experienced a fluctuation of 8.40% , ranging from a day low of $0.7777 to a day high of 0.843. The price has declined in 6 of the last 10 days, resulting in a total change of -8.21% during this period. On the last day, trading volume increase by 171.05K shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 238.59K shares were traded, amounting to approximately 195.00K.
LEXX Technical Signals
LEXX(Lexaria Bioscience Corp Corp) has 4 buy signals and 3 sell signals now. The current trend is downtrend starting from 2025-06-11. The total price change during this trend is -21.01%. Recently, the price has decreased with an increase in volume, indicating a strong bearish signal. The average turnover of LEXX over the last 5 trading days is 102.13K. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
Lexaria Bioscience Corp's overall moving average trend leans more bearish as of Tuesday, August 12, 2025, with 4 negative signals and 0 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $0.95, and $1.01. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $0.76, and $0.71. A break-down below any of these levels will issue sell signals.
LEXX Short Selling Analysis
The short sale ratio of Lexaria Bioscience Corp(LEXX) as of 08 Aug 2025 is 21.78%, dropping from last trading day. With decreasing price from 0.83 to 0.84. The short sell activity indicate that short sellers may be experiencing short cover.
Technical Signal
Technical Signals Summary
Neutral
Sell
3
Buy
4
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
4 Bullish Signals
4 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Stochastic Oscillator %K (14, 3, 3)
STOCHk_14_3_3 < 20
10.767
Bullish
Commodity Channel Index (20 days, 0.015 constant)
CCI_20_0.015 < -100
-114.39
Bullish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 < 20
3.398
Bullish
Williams %R (14 days)
WILLR_14 < -80
-84.148
Bullish
3 Bearish Signals
3 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
LEXX Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Lexaria Bioscience Corp(LEXX), our algorithm predicts LEXX's 1-month price at $0.94, with an 10.71%upwardshift. Using a similarity score up to 93.84%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Lexaria Bioscience Corp (LEXX.O) stock, as of Sunday, August 10, 2025 , forecasts a 10.71% change over the next month, based on its high correlation with HIHO.O stock patterns. The similarity between their price movements over the analyzed periods is 93.84%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
Based on LEXX's historical stock price data across all years, the probability of a positive return in August is40.00%, suggesting it maynotbe an ideal month to invest in LEXX. In contrast,Julyoffers the highest probability of positive returns at60.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Lexaria Bioscience Corp (LEXX.O) stock in July has the highest probability of a positive return (60.00%), while April has the lowest probability (0.00%).
Performance Seasonality
The chart shows Lexaria Bioscience Corp. (LEXX)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
Should I buy Lexaria Bioscience Corp (LEXX.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. LEXX has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying Lexaria Bioscience Corp (LEXX.O) stock in a year?
The radar chart shows that buying Lexaria Bioscience Corp (LEXX.O) stock in July has the highest probability of a positive return (60.00%), while April has the lowest probability (0.00%).
How has Lexaria Bioscience Corp. (LEXX)'s stock price performed over the past three years?
LEXX's stock price fell by -50.98% in 2023,increased by 62.79% in 2024, and went down by 64.28%in 2025.
Is LEXX a buy based on overall technical signals summary?
LEXX has 4 buy signals and 3 sell signals now. Overall the technical rating for LEXX is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of LEXX.
What is the trend of Lexaria Bioscience Corp (LEXX)'s moving average?
Lexaria Bioscience Corp's overall moving average trend leans more bearish as of August 12 2025, with 4 negative signals and 0 positive signal.
What is price prediction for LEXX stock next month?
The price prediction chart for Lexaria Bioscience Corp (LEXX.O) stock, as of August 10 2025, forecasts a 10.71% change over the next month, based on its high correlation with HIHO stock patterns. The similarity between their price movements over the analyzed periods is 93.84%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for LEXX Stock?
The predicted price range for LEXX stock in 2025 is between **$1.20 and $1.50**. This forecast is based on the stock's current price of $1.04, recent news of a $2 million registered direct offering, and the initiation of a biodistribution study for DehydraTECH-semaglutide. While the offering may cause short-term volatility, the study's success could drive long-term growth.
What is price prediction 2030 for LEXX Stock?
LEXX stock could reach **$10 by 2030** if its GLP-1 drug development succeeds and gains significant market share. The stock may drop to **$0.50** if clinical trials fail or market conditions deteriorate. A moderate price of **$3.50** is possible if the company maintains steady progress without major breakthroughs.